<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637974</url>
  </required_header>
  <id_info>
    <org_study_id>CMC-11-0050-CTIL</org_study_id>
    <nct_id>NCT01637974</nct_id>
  </id_info>
  <brief_title>Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery</brief_title>
  <official_title>Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carmel Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carmel Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to examine the influence of INTERCOAT in prevention of intra-uterine
      adhesions formation after any hysteroscopic surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of intra-uterine adhesions in a follow up diagnostic hysteroscopy</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Asherman Syndrome</condition>
  <condition>Endometrial Polyp</condition>
  <condition>Uterine Myoma</condition>
  <arm_group>
    <arm_group_label>with INTERCOAT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection of intercoat into the euterine cavity at the end of hysteroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without INTERCOAT</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>without INTERCOAT</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>INTERCOAT administration</intervention_name>
    <description>Applying INTERCOAT in the intrauterine cavity at the end of the hysteroscopic surgery</description>
    <arm_group_label>with INTERCOAT</arm_group_label>
    <other_name>INTERCOAT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 50 years

          -  Must be able to understand, read and sign consent form

        Exclusion Criteria:

          -  Signs of infection upon admission

          -  Ongoing pregnancy

          -  Carcinoma of the uterus or cervix

          -  Recurrent PID

          -  Women admitted for endometrial ablation

          -  Women that gave birth 6 weeks ago

          -  Women participating in another study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Moran PAZ, M.D.</last_name>
    <phone>972-4-8250637</phone>
    <email>MORANPA@CLALIT.GOV.IL</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yuval Kaufman, M.D.</last_name>
    <phone>972-4-8250345</phone>
    <email>mdykaufman@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moran Paz, MD</last_name>
      <phone>972-4-8250637</phone>
      <email>MORANPA@CLALIT.ORG.IL</email>
    </contact>
    <contact_backup>
      <last_name>Yuval Kaufman, MD</last_name>
      <phone>972-4-8250345</phone>
      <email>mdykaufman@clalit.org.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2012</study_first_posted>
  <last_update_submitted>July 30, 2015</last_update_submitted>
  <last_update_submitted_qc>July 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Carmel Medical Center</investigator_affiliation>
    <investigator_full_name>Moran Paz</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
    <mesh_term>Gynatresia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

